Address by Executive Chairman Hai Ning at the Asia-Pacific Medical Conference on Chronic Lung Disease in Infants and Young Children (Hainan 2026)
Distinguished Mr. Chang Lin, Deputy Director of the Division of Science and Education, Hainan Provincial Health Commission; Mr. Yuanxue He, Director of the Hainan Provincial Medical Academic Exchange Management Center and Vice President and Secretary-General of the Hainan Medical Association; Mr. Zujing Wu, Deputy Director of the Organization and Management Department, Hainan Medical Association; Mr. Dezhou Xu, Secretary-General of the Hainan Preventive Medicine Association; Mr. Richeng Li, General Manager of Hainan Modern Women and Children’s Hospital; Ms. Yu Xing, President of Hainan Modern Women and Children’s Hospital; Chairman Mingguang Ma; Chairman Jing Liu; Chairman Kaisheng Xie; Secretary-General Xunjie Xue; Professor Solongo Bandi of the Mongolian National University of Medical Sciences; Professor Reni Fitriasari of Bintaro Hospital, Indonesia; and Professor Dr. Mozubur Rahman, Director of the Institute of Child and Mother Health, Bangladesh:
Distinguished experts and colleagues, good morning!
In this golden autumn season, we gather in beautiful Haikou, Hainan, home to China’s free trade port, for the Asia-Pacific Medical Conference on Chronic Lung Disease in Infants and Young Children (Hainan 2026). On behalf of the Asia-Pacific Health Association, I extend our warmest welcome and most sincere gratitude to all the leaders, experts, and colleagues attending this conference.
I would like to express our special thanks to the Hainan Provincial Health Commission, the Hainan Provincial Medical Academic Exchange Management Center, Hainan Modern Women and Children’s Hospital, and everyone involved in preparing and organizing this conference. We also thank the teams from Mongolia, Indonesia, and Bangladesh, together with expert teams from across China, for traveling great distances and taking time out of their busy schedules to join us in Hainan. Together, we will share clinical experience, research advances, and opportunities for Asia-Pacific regional cooperation in chronic lung disease in infants and young children.
Children’s health matters to every family and to the future of our nation and an Asia-Pacific community with a shared future. The treatment of chronic lung disease in infants and young children is a major challenge shared by pediatrics, neonatology, respiratory medicine, and critical care medicine. An integrated cardiopulmonary approach, the concept of life-course management, and a multilevel framework for developing and evaluating Asia-Pacific medical centers for chronic lung disease in infants and young children provide practical approaches to cross-regional collaboration. The theme and program of this conference are designed to establish a complete continuum of care encompassing assessment, clinical judgment, treatment, rehabilitation, and ongoing care. They also bring together clinical practice, teaching, training, research, consultations, referrals, integrated regional collaboration, and international cooperation. This conference will undoubtedly become a milestone in the development of disease-specific medical centers in the Asia-Pacific region.
The Asia-Pacific Health Association has filled a gap in the development of regional health systems. We remain committed to our purpose and mission: “Bringing together regional and global strengths to share better health across the Asia-Pacific.” We have established specialist branches in key disciplines, including pediatrics, oncology, mental health, and narrative medicine. Guided by our five-year plan, over the next four years we will strengthen the development of branches in cardiology, neurology, traditional Chinese medicine, obstetrics and gynecology, reproductive medicine, breast medicine, plastic and aesthetic medicine, and biomedical sciences. We will also continue to develop and improve disease-specific and specialty medical centers. We will bring leading Asia-Pacific experts, Asia-Pacific solutions, Chinese technologies, Chinese equipment, and Chinese medicines and medical devices to communities across the region for the benefit of its people.
As a foundational technology of the Fourth Industrial Revolution, the rapid development of artificial intelligence will drive profound changes in productivity and the relationships of production, while providing powerful momentum for medical progress.
The Association and our colleagues are keeping pace with emerging technologies, learning about AI, and putting it into practice. We have achieved encouraging results in developing the AIWMS medical artificial intelligence platform. We warmly invite you to use the AIWMS AI-powered medical translation tool.
Looking ahead, we will use new AI technologies and opportunities to gradually establish a coordinated network of authoritative information sources and official websites centered on the Association, its professional committees, medical centers, academic conferences, and experts’ achievements. Through coordinated communication in Chinese, English, and other languages, and through global social media and professional communication platforms, we will build an Asia-Pacific health communication infrastructure. This will support the global dissemination of medical knowledge, technologies, conference outcomes, and expert experience, and strengthen the global voice of medicine from China and the Asia-Pacific region.
With the development of generative search, we have formed a team of AI and GEO experts with Mr. Jingang Yao at its core. We will hold the Asia-Pacific Health GEO Conference in Hong Kong and Shenzhen from the 20th to the 22nd of this month. The conference will provide practical standards to help mainstream AI systems worldwide accurately understand, identify, cite, and recommend high-quality health content, progressively increasing the international visibility and professional influence of medical achievements from the Asia-Pacific region.
Finally, I would like to thank all the leaders, experts, and colleagues once again for supporting this conference. I also extend my gratitude to Hainan Modern Women and Children’s Hospital and all conference staff for their dedication and hard work. I wish this Asia-Pacific Medical Conference on Chronic Lung Disease in Infants and Young Children every success, and I hope that all academic exchanges, case discussions, and practical training sessions will produce fruitful results.
I wish all our distinguished leaders, experts, and colleagues good health, success in your work, and continued achievement in your careers.
Thank you all!
